RedChip Investor Webinar with Enlivex (NASDAQ: ENLV)
Date & Time:
July 1, 2026 11:00 AM ET (US and Canada)
Enlivex operates a dual-strategic corporate structure that combines clinical development in quality longevity therapeutics with a digital asset treasury strategy centered on the Rain prediction markets protocol. The first engine of this model is Allocetra™, Enlivex’s macrophage reprogramming immunotherapy platform. Allocetra™ is designed to restore immune balance by reprogramming dysregulated macrophages back to their homeostatic state. The therapy is being developed to address inflammatory and degenerative conditions associated with aging, including knee osteoarthritis and additional high-need indications. Positive clinical data in knee osteoarthritis have demonstrated meaningful reductions in pain and improvements in function across treated patients. The second engine of the Enlivex model is its RAIN-based digital asset treasury strategy. Through a $212 million private placement, Enlivex established the first public company treasury strategy centered on a decentralized prediction markets protocol. RAIN functions as a forecasting infrastructure where decentralized markets resolve real-world outcomes through token-based economic mechanisms, including a buyback-and-burn structure. Allocetra™ provides the biological value floor through clinical development in longevity therapeutics, while the RAIN treasury operates as the financial growth engine, giving Enlivex exposure to the expanding decentralized forecasting ecosystem through a Nasdaq-listed structure.
Enlivex operates a dual-strategic corporate structure that combines clinical development in quality longevity therapeutics with a digital asset treasury strategy centered on the Rain prediction markets protocol. The first engine of this model is Allocetra™, Enlivex’s macrophage reprogramming immunotherapy platform. Allocetra™ is designed to restore immune balance by reprogramming dysregulated macrophages back to their homeostatic state. The therapy is being developed to address inflammatory and degenerative conditions associated with aging, including knee osteoarthritis and additional high-need indications. Positive clinical data in knee osteoarthritis have demonstrated meaningful reductions in pain and improvements in function across treated patients. The second engine of the Enlivex model is its RAIN-based digital asset treasury strategy. Through a $212 million private placement, Enlivex established the first public company treasury strategy centered on a decentralized prediction markets protocol. RAIN functions as a forecasting infrastructure where decentralized markets resolve real-world outcomes through token-based economic mechanisms, including a buyback-and-burn structure. Allocetra™ provides the biological value floor through clinical development in longevity therapeutics, while the RAIN treasury operates as the financial growth engine, giving Enlivex exposure to the expanding decentralized forecasting ecosystem through a Nasdaq-listed structure.
Enlivex operates a dual-strategic corporate structure that combines clinical development in quality longevity therapeutics with a digital asset treasury strategy centered on the Rain prediction markets protocol. The first engine of this model is Allocetra™, Enlivex’s macrophage reprogramming immunotherapy platform. Allocetra™ is designed to restore immune balance by reprogramming dysregulated macrophages back to their homeostatic state. The therapy is being developed to address inflammatory and degenerative conditions associated with aging, including knee osteoarthritis and additional high-need indications. Positive clinical data in knee osteoarthritis have demonstrated meaningful reductions in pain and improvements in function across treated patients. The second engine of the Enlivex model is its RAIN-based digital asset treasury strategy. Through a $212 million private placement, Enlivex established the first public company treasury strategy centered on a decentralized prediction markets protocol. RAIN functions as a forecasting infrastructure where decentralized markets resolve real-world outcomes through token-based economic mechanisms, including a buyback-and-burn structure. Allocetra™ provides the biological value floor through clinical development in longevity therapeutics, while the RAIN treasury operates as the financial growth engine, giving Enlivex exposure to the expanding decentralized forecasting ecosystem through a Nasdaq-listed structure.
